Decreased serum orexin A levels in drug-naive children with attention deficit and hyperactivity disorder
- 49 Downloads
Attention deficit/hyperactivity disorder (ADHD) is one of the most common psychiatric disorders of childhood and characterized by inattention, hyperactivity, and impulsivity. ADHD is a neurodevelopmental disorder, and its etiology has not yet been determined precisely. Orexin A is thought to play an important role in different forms of learning, memory, and attention. Despite its importance in attention and learning, no study has investigated serum orexin levels in patients with ADHD. In the present study, we aimed to compare serum orexigenic neuropeptides such as orexin A and orexin B, neuropeptide Y, and ghrelin between drug naive children with ADHD and healthy children. Fifty-six drug-naive children with ADHD and 40 healthy controls were enrolled in the study. After comparison of serum orexin A and orexin B, neuropeptide Y, and ghrelin, we found that serum orexin A levels were significantly lower in the ADHD group (p = 0.001). Furthermore, serum orexin A levels were compared between ADHD subgroups. Orexin A levels were significantly lower in the inattentive subtype compared with the hyperactive subtype and combined subtype (p = 0.009). Our results indicate that orexin A might be a neurobiological etiological factor in ADHD, particularly associated with attention symptoms. The present study is the first to demonstrate decreased serum orexin A levels in drug-naive children with ADHD. Further studies are needed to confirm our results and to show the effects of treatments involving orexin A in patients with ADHD.
KeywordsOrexin Attention Hyperactivity Etiology Neurobiology
The present study was supported by Tekirdağ Namık Kemal University Scientific Research Community (Grant Number: NKUBAP.02.GA.17.09)
Compliance with ethical standards
The present study was approved by the Namık Kemal University Non-Invasive Clinic Research Ethical Committee.
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed). American Psychiatric Publishing, ArlingtonGoogle Scholar
- 5.Caye A, Swanson JM, Coghill D, Rohde LA (2018) Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Mol Psychiatry. https://doi.org/10.1038/s41380-018-0116-3
- 7.Kastin AJ, Akerstrom V (1999) Nonsaturable entry of neuropeptide Y into brain. Am J Phys:E479–E482Google Scholar
- 9.Uriarte M, De Francesco PN, Fernandez G, Cabral A, Castrogiovanni D, Lalonde T, Luyt LG, Trejo S, Perello M (2018) Evidence supporting a role for the blood-cerebrospinal fluid barrier transporting circulating ghrelin into the brain. Mol Neurobiol. https://doi.org/10.1007/s12035-018-1362-8
- 13.Achenbach TM, Edelbrock C (1983) Manual for the child behavior checklist and revised child behavior profile. Queen City Printers, BurlingtonGoogle Scholar
- 19.Borodovitsyna O, Flamini M, Chandler D (2017) Noradrenergic modulation of cognition in health and disease. Neural Plast 2017:6031478Google Scholar
- 22.Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JRS, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573–585CrossRefGoogle Scholar
- 41.Heilig M, Zachrisson O, Thorsell A, Ehnvall A, Mottagui-Tabar S, Sjögren M, Åsberg M, Ekman R, Wahlestedt C, Ågren H (2004) Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J Psychiatr Res 38:113–121CrossRefGoogle Scholar
- 45.Colldén G, Tschöp MH, Müller TD (2017) Therapeutic potential of targeting the ghrelin pathway. Int J Mol Sci 18(4):E798Google Scholar
- 46.Gurbuz F, Gurbuz BB, Celik GG, Yildirim V, Ucakturk SA, Seydaoglu G, Ucakturk EM, Topaloglu AK, Yuksel B (2016) Effects of methylphenidate on appetite and growth in children diagnosed with attention deficit and hyperactivity disorder. Pediatr Endocrinol Metab 29(1):85–92Google Scholar
- 47.Sahin S, Yuce M, Alacam H, Karabekiroglu K, Say GN, Salıs O (2014) Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder. Int J Psychiatry Clin Pract 18(4):280–287CrossRefGoogle Scholar